Inhibiting brain enzyme alleviates depression, and does it much faster than conventional antidepressants

Writing in JAMA, group outlines recommendations for release of regulatory information, analysis, and study data

Researchers  demonstrated their new catalytic template by using it to modify—in a way that was previously impossible—molecules that are commonly found in drugs and other biologically active compounds

Disease and drug response testing from the bottom up

Berkeley Lab invention could lead to dramatic improvements in applications from drug development to bioimaging

UNM Cancer Center scientist co-leads international drug targets effort to create open-source archive for drug discovery, development, and safety

Computational protocol may one day enable drug developers to craft novel, therapeutic peptides that precisely target specific disease-causing molecules within the body

The collaboration will enable the Center for Structured Organic Particulate Systems (C-SOPS) to study new methods for continuous manufacturing.

"What developers need is a safe way of predicting what would happen in a patient's body."

The alliance will promote, develop, and expand research and educational exchange in the neurosciences related to pain, the central nervous system, and other chronic disease